Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients.

Saved in:
Bibliographic Details
Title: Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients.
Authors: Lagoutte-Renosi J; CHU Besancon, F-25000 Besancon, France., Flammang M; CHU Besancon, F-25000 Besancon, France., Chirouze C; CHU Besancon, F-25000 Besancon, France., Beck-Wirth G; Internal Medicine Department, HIV-Infection Care Center, GHR-Mulhouse Sud Alsace, Mulhouse, France., Bozon F; CHU Besancon, F-25000 Besancon, France., Brunel AS; CHU Besancon, F-25000 Besancon, France., Drobacheff-Thiebaut MC; CHU Besancon, F-25000 Besancon, France., Foltzer A; CHU Besancon, F-25000 Besancon, France., Hustache-Mathieu L; CHU Besancon, F-25000 Besancon, France., Kowalczyk J; Internal Medicine Department, HIV-Infection Care Center, GHR-Mulhouse Sud Alsace, Mulhouse, France., Michel C; Internal Medicine Department, HIV-Infection Care Center, GHR-Mulhouse Sud Alsace, Mulhouse, France., Davani S; CHU Besancon, F-25000 Besancon, France., Muret P; CHU Besancon, F-25000 Besancon, France.
Source: Current HIV research [Curr HIV Res] 2021; Vol. 19 (1), pp. 84-89.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101156990 Publication Model: Print Cited Medium: Internet ISSN: 1873-4251 (Electronic) Linking ISSN: 1570162X NLM ISO Abbreviation: Curr HIV Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first